Branchout Food Inc. Faces Continued Decline in Share Price
In the early hours of Friday, 23 September 2026, the shares of Branchout Food Inc. (ticker BOF) slipped –2.29 % over a 24‑hour trading window that closed at 06:30 AM Central European Time. At the time of reporting, one share could be purchased for approximately USD 2.02 on the most liquid exchanges.
Market Snapshot
- Shares Outstanding: 15.3 million
- Market Capitalisation: USD 32.6 million
- Trading Volume (last 24 h): USD 157.4 thousand
- 12‑month Price Range: Highest at USD 5.25 (01 July 2026); Lowest at USD 1.77 (19 October 2026)
- 200‑Day Simple Moving Average: USD 3.71
The current decline continues a broader slide of –42.12 % relative to the end of the previous month, suggesting sustained pressure on investor sentiment.
Comparative Performance of Peer Stocks
In the same 24‑hour window, the following related equities moved as follows:
| Company | Ticker | % Move | Current Price | Market Cap |
|---|---|---|---|---|
| Nanoviricides | NNVC | –7.95 % | USD 1.39 | USD 38.5 M |
| Instil Bio | TIL | –2.86 % | USD 5.70 | USD 39.1 M |
| Brand Engagement Network | BNAI | –0.77 % | USD 4.77 | USD 38.6 M |
| Mind | MIND | +0.47 % | USD 4.11 | USD 38.5 M |
| Liveperson | LVO0.F | 0.00 % | USD 3.10 | USD 38.2 M |
While several peers experienced sharper declines—most notably Nanoviricides—others remained relatively stable or even gained modestly. This mixed performance underscores the sector‑wide volatility that has characterised the market in recent weeks.
Company Overview
Branchout Food Inc. is headquartered in the United States and specialises in the production and marketing of plant‑based dehydrated foods. The firm’s product line includes a variety of fruit and vegetable‑based snacks, such as avocado chips, chewy banana bites, pineapple chips, and Brussels sprout crisps. By leveraging dehydration technology, the company offers shelf‑stable, convenient options for health‑conscious consumers seeking plant‑based alternatives.
Outlook
The recent drop in BOF’s share price, coupled with a steep month‑to‑month decline, may prompt investors to reassess the company’s valuation relative to its growth prospects. Analysts will likely monitor upcoming earnings releases and product‑launch announcements to determine whether the market’s negative sentiment is warranted by fundamentals or driven by broader sectoral dynamics.
